Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

L.A. McKeown

March 30, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Caitlin E. Cox

March 05, 2025

News Daily News

Top Structural Heart News of 2024

L.A. McKeown

December 29, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Caitlin E. Cox

November 15, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Daily News

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

L.A. McKeown

September 26, 2023

News Conference News AATS 2023

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

Michael O'Riordan

May 11, 2023

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

News Daily News

With Some Adjustments, Commissural Alignment Possible With TAVI

Michael O'Riordan

September 16, 2021

News Daily News

Ross Procedure Done Well Holds Up Over Time

Caitlin E. Cox

March 10, 2021

Advertisement

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

Reinterventions Rare Yet Predictable After TAVI, French Registries Show

Top Structural Heart News of 2024

Valvular Heart Disease Has a Diversity Problem

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Many Young Patients With AR Do Not Achieve LV Normalization With Surgery

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Minorities, Poorer Patients Missing Out on Structural Heart Care

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

With Some Adjustments, Commissural Alignment Possible With TAVI

Ross Procedure Done Well Holds Up Over Time

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content